Diagnostic and prognostic implications of 2018 guideline for the diagnosis of idiopathic pulmonary fibrosis in clinical practice

被引:0
|
作者
Jooae Choe
Byoung Soo Kwon
Kyung-Hyun Do
Hee Sang Hwang
Jin Woo Song
Eun Jin Chae
机构
[1] Asan Medical Center,Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine
[2] Seoul National University Bundang Hospital,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
[3] Asan Medical Center,Department of Pathology, University of Ulsan College of Medicine
[4] University of Ulsan College of Medicine,Department of Pulmonology and Critical Care Medicine
[5] Asan Medical Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to evaluate the implications of the 2018 updated guideline for the diagnosis of idiopathic pulmonary fibrosis (IPF) in clinical practice compared to 2011 guideline. This study involved 535 patients including 339 IPF and 196 non-IPF, and we retrospectively evaluated CT classifications of usual interstitial pneumonia (UIP) by two guidelines. Interobserver agreement of 2018 criteria showed moderate reliability (κ = 0.53) comparable to 2011 (κ = 0.56) but interobserver agreement for probable UIP was fair (κ = 0.40). CT pattern of indeterminate for UIP was associated with better prognosis compared with the other groups (adjusted hazard ratio [HR] = 0.36, p < 0.001). Compared to possible UIP, probable UIP demonstrated a lower positive predictive value (PPV, 62.9% vs 65.8%). In analysis of patients with CT patterns of non-definite UIP, diagnosing IPF when CT pattern showed probable UIP with lymphocyte count ≤ 15% in BAL fluid, and either male sex or age ≥ 60 years showed a high specificity of 90.6% and a PPV of 80.8% in the validation cohort. The 2018 criteria provide better prognostic stratification than the 2011 in patients with possible UIP. BAL fluid analysis can improve the diagnostic certainty for IPF diagnosis in patients with probable UIP CT pattern.
引用
收藏
相关论文
共 50 条
  • [31] Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
    Poletti, Venerino
    EUROPEAN RESPIRATORY REVIEW, 2014, 23 (131): : 3 - 4
  • [32] Diagnosis and management of idiopathic pulmonary fibrosis: Implications for respiratory care
    Hospenthal, MAC
    RESPIRATORY CARE, 2006, 51 (04) : 382 - 391
  • [33] Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study
    Walsh, Simon L. F.
    Maher, Toby M.
    Kolb, Martin
    Poletti, Venerino
    Nusser, Richard
    Richeldi, Luca
    Vancheri, Carlo
    Wilsher, Margaret L.
    Antoniou, Katerina M.
    Behr, Juergen
    Bendstrup, Elisabeth
    Brown, Kevin
    Calandriello, Lucio
    Corte, Tamera J.
    Cottin, Vincent
    Crestani, Bruno
    Flaherty, Kevin
    Glaspole, Ian
    Grutters, Jan
    Inoue, Yoshikazu
    Kokosi, Maria
    Kondoh, Yasuhiro
    Kouranos, Vasileios
    Kreuter, Michael
    Johannson, Kerri
    Judge, Eoin
    Ley, Brett
    Margaritopoulos, George
    Martinez, Fernando J.
    Molina-Molina, Maria
    Morais, Antonio
    Nunes, Hilario
    Raghu, Ganesh
    Ryerson, Christopher J.
    Selman, Moises
    Spagnolo, Paolo
    Taniguchi, Hiroyuki
    Tomassetti, Sara
    Valeyre, Dominique
    Wijsenbeek, Marlies
    Wuyts, Wim
    Hansell, David
    Wells, Athol
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [34] IDENTIFICATION OF CLINICAL PROGNOSTIC PARAMETERS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Rogers, K.
    Hadinnapola, C.
    Sylvester, K.
    Toshner, M.
    Parfrey, H.
    THORAX, 2016, 71 : A14 - A14
  • [35] Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis
    Wallaert, B.
    Guetta, A.
    Wemeau-Stervinou, L.
    Terce, G.
    Valette, M.
    Neviere, R.
    Aguilaniu, B.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (03) : 290 - 296
  • [36] Pulmonary fibrosis idiopathic: Diagnostic study with 10 clinical actions
    Morell, Ferran
    Villar, Ana
    MEDICINA CLINICA, 2017, 149 (06): : 253 - 255
  • [37] Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis
    Marinescu, Daniel-Costin
    Raghu, Ganesh
    Remy-Jardin, Martine
    Travis, William D.
    Adegunsoye, Ayodeji
    Beasley, Mary Beth
    Chung, Jonathan H.
    Churg, Andrew
    Cottin, Vincent
    Egashira, Ryoko
    Perez, Evans R. Fernandez
    Inoue, Yoshikazu
    Johannson, Kerri A.
    Kazerooni, Ella A.
    Khor, Yet H.
    Lynch, David A.
    Muller, Nestor L.
    Myers, Jeffrey L.
    Nicholson, Andrew G.
    Rajan, Sujeet
    Saito-Koyama, Ryoko
    Troy, Lauren
    Walsh, Simon L. F.
    Wells, Athol U.
    Wijsenbeek, Marlies S.
    Wright, Joanne L.
    Ryerson, Christopher J.
    CHEST, 2022, 162 (03) : 614 - 629
  • [38] Japanese guideline for the treatment of idiopathic pulmonary fibrosis
    Homma, Sakae
    Bando, Masashi
    Azuma, Arata
    Sakamoto, Susumu
    Sugino, Keishi
    Ishii, Yoshiki
    Izumi, Shinyu
    Inase, Naohiko
    Inoue, Yoshikazu
    Ebina, Masahito
    Ogura, Takashi
    Kishi, Kazuma
    Kishaba, Tomoo
    Kido, Takashi
    Gemma, Akihiko
    Goto, Yoshihito
    Sasaki, Shinichi
    Johkoh, Takeshi
    Suda, Takafumi
    Takahashi, Kazuhisa
    Takahashi, Hiroki
    Taguchi, Yoshio
    Date, Hiroshi
    Taniguchi, Hiroyuki
    Nakayama, Takeo
    Nishioka, Yasuhiko
    Hasegawa, Yoshinori
    Hattori, Noboru
    Fukuoka, Junya
    Miyamoto, Atsushi
    Mukae, Hiroshi
    Yokoyama, Akihito
    Yoshino, Ichiro
    Watanabe, Kentaro
    RESPIRATORY INVESTIGATION, 2018, 56 (04) : 268 - 291
  • [39] Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosis
    Bando, Masashi
    RESPIRATORY INVESTIGATION, 2016, 54 (05) : 298 - 304
  • [40] New guideline on treatment of idiopathic pulmonary fibrosis
    Spagnolo, Paolo
    Bonella, Francesco
    Maher, Toby M.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (09): : E31 - E32